Severe tuberculosis while on infliximab (Cont'd)

Prescrire International

Volumn 11, Issue 59, 2002, Pages 87-

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; STEROID; TUBERCULOSTATIC AGENT;

AGE; ARTICLE; ASPERGILLOSIS; CANDIDIASIS; CROHN DISEASE; DISEASE SEVERITY; DOSE RESPONSE; DRUG SURVEILLANCE PROGRAM; EXTRAPULMONARY TUBERCULOSIS; HISTOPLASMOSIS; HUMAN; INFECTION RISK; LISTERIOSIS; MILIARY TUBERCULOSIS; MORTALITY; OPPORTUNISTIC INFECTION; PNEUMONIA; RHEUMATOID ARTHRITIS; TIME; TUBERCULOUS LYMPHADENITIS; TUBERCULOUS MENINGITIS; TUBERCULOUS PERITONITIS; TUBERCULOUS PLEURISY;

EID: 85047656268     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Centocor "Important drug warning - Remicade°" 5 October 2001. Website http://www.fda.gov consulted on 23 October 2001.
2. Prescrire Rédaction "Tuberculose grave sous infliximab" Rev Prescr 2001: 21 (214): 122.
3. Keane J et al. "Tuberculosis associated with infliximab, a tumor necrosis factor a-neutralizing agent" N Engl J Med 2001; 345 (15): 1098-1104.
4. The European Agency for the Evaluation of Medicinal Products "EMEA public statement on infliximab (Remicade) - Update on safety concerns" 1 February 2002. Website http://emea.eu.int consulted on 1 February 2002.
5. French datasheet compendium "Dictionnaire Vidal" Vidal, Paris 2002.